Occupational asthma caused by carnation (Dianthus caryophyllus) with simultaneous IgE‐mediated sensitization to Tetranychus urticae

Tetranychus urticae (TU) is a known occupational allergen which frequently parasitizes carnations (Dianthus caryophyllus) (1). Therefore, the investigation of occupational allergy caused by carnation implies nonconsideration of TU as a causative agent. A case of occupational respiratory allergy to carnation, with simultaneous sensitization to TU in the same patient, is described. A 29-year-old woman, smoking 15 cigarettes per day, with neither personal history of atopia nor other antecedents of interest, having been employed at a flower supplier during the previous 2 years, was studied at our allergy unit. She had sneezing, rhinorrhea, coughing, wheezing and dyspnea while cleaning carnations at the flower shop. She also showed no respiratory symptoms in relation with other flowers. During holidays the patient was totally asymptomatic. Two carnation extracts, from petals and stems, were prepared (ALK-Abelló, Madrid, Spain). Only fresh flowers not infested by TU were used. Additionally, two TU extracts, from TU scratched from infested carnation leaves (TU-S) and from isolated bodies of TU (TU-B) were obtained (BIAL-ARISTEGUI, Bilbao, Spain) as previously described (1). Skin prick tests (SPT) with carnation stem (at 5% w/v), petal (at 2.5% w/v) and the two TU (at 1 mg/ml) extracts were positive. Simultaneously, negative response was obtained with a battery of frequent inhalants. SPT with carnation and TU extracts were negative in 10 atopic and 10 nonatopic patients who were used as control subjects. Total IgE was 203 kU/l. Serum-specific IgE [radioallergosorbent test (RAST)] to both petals and stem extracts was RAST class 3. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE) immunoblotting showed two IgEbinding bands of 25 and 28 kDa present both in carnation petal and stem extract. In both TU extracts, four protein IgEbinding bands of 67.1, 48.8, 33.7, and 18.8 kDa were visible. Thirteen additional bands, ranging from 16.9 to 83.0 kDa, were detected in the TU-S extract which may be due to a contamination with carnation allergenic proteins. Metacholine challenge test showed bronchial hyperreactivity (5 mg/ml). Specific bronchial provocation test with a dilution of 1/64 of carnation stem extract (10% w/v) was positive, eliciting a dual response. Occupational asthma caused by carnation was diagnosed. As bronchial challenge test with TU-B extract was negative, being administered the maximum concentration of 1 mg/ml, asthma from TU could not be confirmed. In this case, a subclinical sensitization to TU or rhinitis caused by TU is possible. Additionally, it cannot be ruled out that administering higher TU doses during bronchial challenge test might have triggered an asthmatic reaction. Respiratory allergy to carnation has been described before (2–4) and, in this latest paper, a simultaneous sensitization to TU in the same patient is proved. Nevertheless, in the two latest articles there is no mention of the use of extracts from flowers in which parasitization by TU had been ruled out. However, it is important to keep this in mind in order to reach the right etiology, given that carnation industry workers may be doubly sensitized, as described above, or even to be sensitized to TU, but not to carnation proteins as proved by Delgado et al. in 16 workers who handled carnations at a greenhouse (1). Vidal et al. (2) proved type-I hypersensitivity to proteins from carnation and other flowers in a patient, without considering allergy to TU. However, bronchial provocation test was not performed because the patient showed rhinitis but not asthma. This case proves that in carnation workers showing respiratory symptoms, it is essential to investigate the flowers and their parasite TU separately, given that, either one of them, or both simultaneously, could act as an occupational allergen. We thank Margarita Encinas, Mercedes Lucı́a and Nuria González, nurses of Hospital of Segovia. The authors are indebted to Dr Julio Delgado (Hospital Univ. Virgen Macarena, Sevilla, Spain) for kindly providing TU samples for extract preparations and also to Alejandro Enrı́quez de Salamanca for the English correction of the manuscript.

[1]  C. Bindslev‐Jensen,et al.  Delayed‐type hypersensitivity to heparins , 2004, Allergy.

[2]  J. Malo,et al.  Definitions and types of work-related asthma: a nosological approach , 2003, European Respiratory Journal.

[3]  L. Butani Corticosteroid-induced hypersensitivity reactions. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  P. Giangrande,et al.  FONDAPARINUX (ARIXTRA®): A NEW ANTICOAGULANT , 2002, The Medical letter on drugs and therapeutics.

[5]  J. Belchí,et al.  Delayed‐type hypersensitivity skin reactions to low molecular weight heparins in a pregnant woman , 2002, Contact dermatitis.

[6]  J. Bartra,et al.  Urticaria to cetirizine. , 2002, Journal of investigational allergology & clinical immunology.

[7]  Y. Ahn,et al.  Occupational asthma due to formaldehyde. , 2001, Yonsei medical journal.

[8]  P. Fritsch,et al.  Delayed‐Type Hypersensitivity and Cross‐Reactivity to Heparins and Danaparoid: A Prospective Study , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[9]  J. Blumer,et al.  Safety of Antihistamines in Children , 2001, Drug safety.

[10]  E. de Maistre,et al.  [Cutaneous delayed hypersensitivity reactions to heparins and heparinoids]. , 2001, Annales de dermatologie et de venereologie.

[11]  E. Enrique,et al.  Simultaneous occupational allergy to a carnation and its parasite in a greenhouse worker. , 2000, The Journal of allergy and clinical immunology.

[12]  E. Juniper,et al.  Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  L. Salmun,et al.  The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years. , 2000, Clinical therapeutics.

[14]  P. Koch,et al.  Delayed allergic skin reactions to subcutaneous heparins. Tolerance of 2 recombinant hirudins. , 2000, Contact dermatitis.

[15]  J. Roujeau,et al.  Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? , 2000, Archives of dermatology.

[16]  W. Pichler,et al.  Drug-Induced Linear IgA Bullous Dermatosis Associated with Ceftriaxone- and Metronidazole-Specific T Cells , 1999, Dermatology.

[17]  R. Palacios,et al.  Occupational allergy caused by carnation (Dianthus caryophyllus). , 1999, The Journal of allergy and clinical immunology.

[18]  C. Bayerl,et al.  Association of heparin‐induced skin lesions, intracutaneous tests, and heparin‐induced IgG , 1999, Allergy.

[19]  C. Vidal,et al.  Occupational allergy caused by Dianthus caryophillus, Gypsophila paniculata, and Lilium longiflorum , 1998, Allergy.

[20]  J. DELGADO,et al.  Occupational allergy in greenhouse workers: sensitization to Tetranychus urticae , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  G. Cantó,et al.  Fixed drug eruption induced by lidocaine and patch testing. , 1997, Journal of investigational allergology & clinical immunology.

[22]  A. Moreau,et al.  Delayed hypersensitivity at the injection sites of a low‐molecular‐weight heparin , 1996, Contact dermatitis.

[23]  C. Rondón,et al.  Fixed drug eruption induced by mepivacaine. , 1995, The Journal of allergy and clinical immunology.

[24]  K. Alanko Topical provocation of fixed drug eruption A study of 30 patients , 1994, Contact dermatitis.

[25]  P. Górski,et al.  The case of TDI-induced reactive airway dysfunction syndrome with the presence of specific IgE antibodies. , 1994, Allergologia et Immunopathologia.

[26]  G. Ciprandi,et al.  Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. , 1994, Drugs.

[27]  D. Fung,et al.  Anaphylactic and anaphylactoid reactions due to anesthetic agents , 1986, Clinical reviews in allergy.

[28]  H. Keskinen,et al.  Formaldehyde asthma--rare or overlooked? , 1985, The Journal of allergy and clinical immunology.

[29]  D J Lane,et al.  Occupational formalin asthma. , 1977, British journal of industrial medicine.